Saikat Chakrabarti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Saikat Chakrabarti has a total of 168 co-authors. Here are the top co-authors by number of shared publications:
Subhrangshu Das
Structural Biology and Bioinformatics Division, CSIR-Indian Institute of Chemical Biology, IICB TRUE Campus, CN-6, Sector 5, Salt Lake, Kolkata, 700091, WB, India
8 shared publications- Oishee Chakrabarti
Saha Institute of Nuclear physics
7 shared publications Sarpita Bose
Structural Biology and Bioinformatics Division, CSIR-Indian Institute of Chemical Biology, IICB TRUE Campus, CN-6, Sector 5, Salt Lake, Kolkata, 700091, WB, India
7 shared publications- Ishita Mukherjee
Structural Biology and Bioinformatics Division, Council for Scientific and Industrial Research (CSIR) - Indian Institute of Chemical Biology (IICB), Kolkata, West Bengal 700032, India
6 shared publications Izaz Monir Kamal
Structural Biology and Bioinformatics Division, CSIR Indian Institute of Chemical Biology
6 shared publicationsPriyanka Mallick
Structural Biology and Bioinformatics Division, CSIR-Indian Institute of Chemical Biology, IICB TRUE Campus
6 shared publications
Latest Publications
- Open Access
- 9 October 2026
- Published by Frontiers Media SA in Frontiers in Bioinformatics
- Vol. 6, 1897635
Exploring molecular interactions between yeast topoisomerase I and RNA polymerase III subunit, Rpc82 using an in-silico approach
Introduction: The process of DNA transcription leads to the generation of torsional stress, which must be resolved for smooth progression of the transcription machinery. In Saccharomyces cerevisiae, DNA topoisomerase I (Top I), a type IB topoisomerase, plays a critical role in relaxing supercoils and mitigating the topological strain associated with transcription. While several proteins from the transcription machinery have been reported to interact with yeast Top I, the precise structural domains involved and the detailed features of the interaction interfaces remain largely unexplored. This gap is partly due to the absence of a complete three-dimensional structure of the full-length enzyme, which hinders structure-based computational analyses of its interactome. Methods: A full-length model of yeast Top I was generated using a domain-based modeling approach and evaluated using structural validation metrics and comparative analyses with homologous structures. Leveraging this model, we investigated a potential interaction between Top I and Rpc82, a key subunit of RNA polymerase III involved in transcription of small non-coding RNAs such as tRNAs and 5S rRNA. The interaction was evaluated using an integrative computational approach combining molecular docking, binding free-energy calculations, and molecular dynamics simulations. Results: The analyses identified a putative interaction interface involving the WH2–WH3 region of Rpc82 and primarily the D1 and D3 domains of Top I. Molecular dynamics simulations indicated that the predicted Top I–Rpc82 complex remained structurally stable under the simulated conditions. The calculated binding energy-to-surface-area ratio of the complex was comparable to benchmark values for biologically relevant heterodimeric protein interfaces, supporting the plausibility of the predicted interaction. Discussion/Conclusions: Overall these findings provide a structural framework for future experimental validation of Top I interactions, paving the way for mechanistic insights into its regulatory functions and contribution to genome maintenance and stability.
- 9 October 2026
- Published by Frontiers Media SA in Frontiers in Bioinformatics
- Vol. 6, 1897635
Open AccessExploring molecular interactions between yeast topoisomerase I and RNA polymerase III subunit, Rpc82 using an in-silico approach
Introduction: The process of DNA transcription leads to the generation of torsional stress, which must be resolved for smooth progression of the transcription machinery. In Saccharomyces cerevisiae, DNA topoisomerase I (Top I), a type IB topoisomerase, plays a critical role in relaxing supercoils and mitigating the topological strain associated with transcription. While several proteins from the transcription machinery have been reported to interact with yeast Top I, the precise structural domains involved and the detailed features of the interaction interfaces remain largely unexplored. This gap is partly due to the absence of a complete three-dimensional structure of the full-length enzyme, which hinders structure-based computational analyses of its interactome. Methods: A full-length model of yeast Top I was generated using a domain-based modeling approach and evaluated using structural validation metrics and comparative analyses with homologous structures. Leveraging this model, we investigated a potential interaction between Top I and Rpc82, a key subunit of RNA polymerase III involved in transcription of small non-coding RNAs such as tRNAs and 5S rRNA. The interaction was evaluated using an integrative computational approach combining molecular docking, binding free-energy calculations, and molecular dynamics simulations. Results: The analyses identified a putative interaction interface involving the WH2–WH3 region of Rpc82 and primarily the D1 and D3 domains of Top I. Molecular dynamics simulations indicated that the predicted Top I–Rpc82 complex remained structurally stable under the simulated conditions. The calculated binding energy-to-surface-area ratio of the complex was comparable to benchmark values for biologically relevant heterodimeric protein interfaces, supporting the plausibility of the predicted interaction. Discussion/Conclusions: Overall these findings provide a structural framework for future experimental validation of Top I interactions, paving the way for mechanistic insights into its regulatory functions and contribution to genome maintenance and stability.
- 20 September 2026
- Published by Wiley in European Journal of Neuroscience
- Vol. 64 (6) , e70684
Transcriptional Alteration in TRK β ‐SHC Isoform as a Neuroprotective Factor for Post‐Stroke Memory Outcomes
Post‐stroke cognitive impairment (PSCI) affects nearly 30% of stroke survivors and substantially limits functional recovery. Brain‐derived neurotrophic factor (BDNF)–tropomyosin receptor kinase‐ β (Trk β ) signalling plays an important role in synaptic plasticity and cognitive function; however, the contribution of individual NTRK2/Trk β isoforms to PSCI remains poorly understood. This study investigated (a) isoform‐specific NTRK2 mRNA expression, (b) genetic association of the isoform‐specific variant rs6559833 with post‐stroke cognitive outcomes and (c) DNA methylation patterns potentially regulating NTRK2 expression using blood as primary biosource. Isoform‐specific expression was analysed in 50 subjects, rs6559833 was genotyped in 280 ischemic stroke patients, and DNA methylation was assessed in 10 samples using whole‐genome bisulfite sequencing. The TRK β ‐FL expression was significantly reduced in stroke patients compared with healthy controls, whereas TRK β ‐SHC expression was higher in PSCN individuals than in PSCI patients. The latter showed positive correlation with MEK2 expression and memory performance. The ‘TT’ genotype of the rs6559833 variant showed marginal associations with post‐stroke memory status and overall BMSE scores ( p = 0.0442 and 0.0488, respectively). Furthermore, hypermethylation was observed within the NTRK2 gene body and in genes encoding its splicing regulators, whereas no evident difference in promoter methylation was observed. Collectively, these findings suggest that Trk β ‐SHC expression may be associated with preserved cognitive function after stroke and indicate a potential relationship between isoform‐specific NTRK2 expression, genetic regulation and cognitive outcomes in PSCI.
- 20 September 2026
- Published by Wiley in European Journal of Neuroscience
- Vol. 64 (6) , e70684
Transcriptional Alteration in TRK β ‐SHC Isoform as a Neuroprotective Factor for Post‐Stroke Memory Outcomes
Post‐stroke cognitive impairment (PSCI) affects nearly 30% of stroke survivors and substantially limits functional recovery. Brain‐derived neurotrophic factor (BDNF)–tropomyosin receptor kinase‐ β (Trk β ) signalling plays an important role in synaptic plasticity and cognitive function; however, the contribution of individual NTRK2/Trk β isoforms to PSCI remains poorly understood. This study investigated (a) isoform‐specific NTRK2 mRNA expression, (b) genetic association of the isoform‐specific variant rs6559833 with post‐stroke cognitive outcomes and (c) DNA methylation patterns potentially regulating NTRK2 expression using blood as primary biosource. Isoform‐specific expression was analysed in 50 subjects, rs6559833 was genotyped in 280 ischemic stroke patients, and DNA methylation was assessed in 10 samples using whole‐genome bisulfite sequencing. The TRK β ‐FL expression was significantly reduced in stroke patients compared with healthy controls, whereas TRK β ‐SHC expression was higher in PSCN individuals than in PSCI patients. The latter showed positive correlation with MEK2 expression and memory performance. The ‘TT’ genotype of the rs6559833 variant showed marginal associations with post‐stroke memory status and overall BMSE scores ( p = 0.0442 and 0.0488, respectively). Furthermore, hypermethylation was observed within the NTRK2 gene body and in genes encoding its splicing regulators, whereas no evident difference in promoter methylation was observed. Collectively, these findings suggest that Trk β ‐SHC expression may be associated with preserved cognitive function after stroke and indicate a potential relationship between isoform‐specific NTRK2 expression, genetic regulation and cognitive outcomes in PSCI.
- 7 July 2026
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 41 (1)
Genetic and structural characterisation of alzheimer’s disease associated variants in an Eastern Indian cohort
Alzheimer's disease (AD) shows substantial clinical heterogeneity often caused by genetic variants contributing to both familial and early-onset forms. However, the genetic landscape of AD in the diverse Indian population remains further characterised. To identify probable pathogenic variants associated with AD, representing individuals from Eastern India and to assess their potential structural effects using molecular dynamics (MD) simulations. Whole-exome sequencing was performed in 29 radiologically confirmed AD patients. Variants identified were screened using standard in silico prediction tools and categorised according to their involvement in amyloid precursor protein (APP)-related and non-APP pathways. Molecular dynamics simulations of filtered variants in PSEN1, SORL1, and ABCA7 genes were conducted using GROMACS 2024 to assess conformational stability, flexibility (RMSD, RMSF), compactness (Rg), and solvent accessibility (SASA). Thirty-six variants across 18 genes were identified, including five pathogenic variants and 31 variants of uncertain significance. Frequently affected genes included ABCA7 (8 variants), SORL1 (3 variants), PSEN1 (two novel variants), and APP (London mutation, Val717Ile). Most patients (83.3%) had a positive family history, with a mean age at onset of 54.17 ± 11.74 years, presenting with typical AD, posterior cortical atrophy, or frontal variants. MD simulations revealed increased rigidity, altered electrostatic interactions, and disrupted ATP-binding dynamics in mutant proteins compared with wild type. This study identifies novel and known AD-associated variants in an Indian cohort and demonstrates their potential structural impact. Integrating genetic and structural analyses provides valuable insights into AD pathogenesis in underrepresented populations.
- 7 July 2026
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 41 (1)
Genetic and structural characterisation of alzheimer’s disease associated variants in an Eastern Indian cohort
Alzheimer's disease (AD) shows substantial clinical heterogeneity often caused by genetic variants contributing to both familial and early-onset forms. However, the genetic landscape of AD in the diverse Indian population remains further characterised. To identify probable pathogenic variants associated with AD, representing individuals from Eastern India and to assess their potential structural effects using molecular dynamics (MD) simulations. Whole-exome sequencing was performed in 29 radiologically confirmed AD patients. Variants identified were screened using standard in silico prediction tools and categorised according to their involvement in amyloid precursor protein (APP)-related and non-APP pathways. Molecular dynamics simulations of filtered variants in PSEN1, SORL1, and ABCA7 genes were conducted using GROMACS 2024 to assess conformational stability, flexibility (RMSD, RMSF), compactness (Rg), and solvent accessibility (SASA). Thirty-six variants across 18 genes were identified, including five pathogenic variants and 31 variants of uncertain significance. Frequently affected genes included ABCA7 (8 variants), SORL1 (3 variants), PSEN1 (two novel variants), and APP (London mutation, Val717Ile). Most patients (83.3%) had a positive family history, with a mean age at onset of 54.17 ± 11.74 years, presenting with typical AD, posterior cortical atrophy, or frontal variants. MD simulations revealed increased rigidity, altered electrostatic interactions, and disrupted ATP-binding dynamics in mutant proteins compared with wild type. This study identifies novel and known AD-associated variants in an Indian cohort and demonstrates their potential structural impact. Integrating genetic and structural analyses provides valuable insights into AD pathogenesis in underrepresented populations.
- Open Access
Computational insights into the interaction between Topoisomerase I and Rpc82 subunit of RNA Polymerase III in Saccharomyces cereviseae
The process of DNA transcription leads to the generation of torsional stress, which must be resolved for smooth progression of the transcription machinery. In Saccharomyces cerevisiae , DNA topoisomerase I (Top1), a type IB topoisomerase, plays a critical role in relaxing supercoils and mitigating the topological strain associated with transcription. While several proteins from the transcription machinery have been reported to interact with yeast Top1, detailed characterization and functional relevance of these interactions have remained underexplored. This gap is partly due to the absence of a complete three-dimensional structure of the full-length enzyme, which hinders structure-based computational analyses of its interactome. In this study, we present a template-based model of full-length yeast Top1. Leveraging this model, we investigated its molecular interaction with Rpc82, a key subunit of RNA polymerase III enzyme, responsible for transcribing small non-coding RNAs such as tRNAs and 5S rRNA. Through molecular docking and molecular dynamics simulations, critical residues at the Top1–Rpc82 interface were identified that likely mediate their interaction. Our findings provide new insights into the structural basis of Top1′s association with RNA polymerase III and its potential role in regulating Pol III-mediated transcription. The Top1 model developed here offers a valuable framework for future in silico studies aimed at elucidating the broader interactome and regulatory mechanisms of this essential enzyme.
Open AccessComputational insights into the interaction between Topoisomerase I and Rpc82 subunit of RNA Polymerase III in Saccharomyces cereviseae
The process of DNA transcription leads to the generation of torsional stress, which must be resolved for smooth progression of the transcription machinery. In Saccharomyces cerevisiae , DNA topoisomerase I (Top1), a type IB topoisomerase, plays a critical role in relaxing supercoils and mitigating the topological strain associated with transcription. While several proteins from the transcription machinery have been reported to interact with yeast Top1, detailed characterization and functional relevance of these interactions have remained underexplored. This gap is partly due to the absence of a complete three-dimensional structure of the full-length enzyme, which hinders structure-based computational analyses of its interactome. In this study, we present a template-based model of full-length yeast Top1. Leveraging this model, we investigated its molecular interaction with Rpc82, a key subunit of RNA polymerase III enzyme, responsible for transcribing small non-coding RNAs such as tRNAs and 5S rRNA. Through molecular docking and molecular dynamics simulations, critical residues at the Top1–Rpc82 interface were identified that likely mediate their interaction. Our findings provide new insights into the structural basis of Top1′s association with RNA polymerase III and its potential role in regulating Pol III-mediated transcription. The Top1 model developed here offers a valuable framework for future in silico studies aimed at elucidating the broader interactome and regulatory mechanisms of this essential enzyme.
- 1 November 2025
- Published by Springer Nature
- Vol. 2979, 65-81
Co-Var, a Measure to Determine Intra-protein, Inter-protein, Protein–DNA, or Protein–RNA Coevolution
Interacting biomolecules tend to coevolve, and compensatory or coordinated residue changes may occur to preserve functional interactions. Predicting coevolutionary pairings could be important for determining structurally and functionally important residues in complexes or interfaces. Correlated variation (Co-Var) aims to determine both intramolecular and intermolecular coevolving residues in proteins, protein–protein, protein–DNA, or protein–RNA complexes. It utilizes two statistical parameters namely mutual information and Bhattacharyya coefficient. In this article, we have described how to utilize the Co-Var method to identify coevolutionary parings within and/or across biomolecules.
- 1 November 2025
- Published by Springer Nature
- Vol. 2979, 65-81
Co-Var, a Measure to Determine Intra-protein, Inter-protein, Protein–DNA, or Protein–RNA Coevolution
Interacting biomolecules tend to coevolve, and compensatory or coordinated residue changes may occur to preserve functional interactions. Predicting coevolutionary pairings could be important for determining structurally and functionally important residues in complexes or interfaces. Correlated variation (Co-Var) aims to determine both intramolecular and intermolecular coevolving residues in proteins, protein–protein, protein–DNA, or protein–RNA complexes. It utilizes two statistical parameters namely mutual information and Bhattacharyya coefficient. In this article, we have described how to utilize the Co-Var method to identify coevolutionary parings within and/or across biomolecules.
- Open Access
- 29 July 2025
- Published by Springer Nature in Cell Death & Disease
- Vol. 16 (1) , 1-16
The impact of ERUPR on mitochondrial integrity mediated by PDK4
ER and mitochondrial stress are often interconnected and considered major contributors to aging as well as neurodegeneration. Coordinated induction of ERUPR and mitoUPR has been observed in diabetes and pulmonary disorders. However, in the context of aging and neurodegeneration, regulation of this intra-organellar crosstalk has remained relatively elusive. Here, we demonstrate that pyruvate dehydrogenase kinase 4 (PDK4), a mitochondrial protein, accumulates at the ER-mitochondrial contact sites (MAMs) during ER stress. Classically, PDK4 is known to phosphorylate PDHA1 (pyruvate dehydrogenase E1 subunit alpha 1) and plays a significant role in regulating the oxidative phosphorylation-driven ATP production. In this study, we propose a non-canonical kinase-independent function of PDK4; we show that it acts as a connecting link between ERUPR and mitoUPR, with significance in aging and Alzheimer’s disease (AD) associated neurodegeneration. Transcriptomics analyses show increased PDK4 levels upon drug-induced ER stress. We detect elevated PDK4 levels in lysates from human AD patient and mouse models as well as in ex vivo AD models. Additionally, exogenous expression of PDK4 was found to refine ER-mitochondria communication, significantly altering mitochondrial morphology and function. Further, we also observe defective autophagic clearance of mitochondria under such conditions. It is prudent to suggest that elevated PDK4 levels could be one of the key factors connecting ERUPR with mitoUPR, a phenotypic contributor in aging and in AD-like neurodegenerative disorders.
- 29 July 2025
- Published by Springer Nature in Cell Death & Disease
- Vol. 16 (1) , 1-16
Open AccessThe impact of ERUPR on mitochondrial integrity mediated by PDK4
ER and mitochondrial stress are often interconnected and considered major contributors to aging as well as neurodegeneration. Coordinated induction of ERUPR and mitoUPR has been observed in diabetes and pulmonary disorders. However, in the context of aging and neurodegeneration, regulation of this intra-organellar crosstalk has remained relatively elusive. Here, we demonstrate that pyruvate dehydrogenase kinase 4 (PDK4), a mitochondrial protein, accumulates at the ER-mitochondrial contact sites (MAMs) during ER stress. Classically, PDK4 is known to phosphorylate PDHA1 (pyruvate dehydrogenase E1 subunit alpha 1) and plays a significant role in regulating the oxidative phosphorylation-driven ATP production. In this study, we propose a non-canonical kinase-independent function of PDK4; we show that it acts as a connecting link between ERUPR and mitoUPR, with significance in aging and Alzheimer’s disease (AD) associated neurodegeneration. Transcriptomics analyses show increased PDK4 levels upon drug-induced ER stress. We detect elevated PDK4 levels in lysates from human AD patient and mouse models as well as in ex vivo AD models. Additionally, exogenous expression of PDK4 was found to refine ER-mitochondria communication, significantly altering mitochondrial morphology and function. Further, we also observe defective autophagic clearance of mitochondria under such conditions. It is prudent to suggest that elevated PDK4 levels could be one of the key factors connecting ERUPR with mitoUPR, a phenotypic contributor in aging and in AD-like neurodegenerative disorders.
- 21 May 2025
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 606, 112583
Androgen receptor plays critical role in regulating cervical cancer cell migration
- 21 May 2025
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 606, 112583
Androgen receptor plays critical role in regulating cervical cancer cell migration
- 1 January 2025
- Published by Springer Nature
- p. 323-344
COVID-19 Target-Based Drug Discovery
- 1 November 2024
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 282 (Pt 4) , 137154
Mutational and evolutionary dynamics of non-structural and spike proteins from variants of concern (VOC) of SARS-CoV-2 in India
- 1 November 2024
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 282 (Pt 4) , 137154
Mutational and evolutionary dynamics of non-structural and spike proteins from variants of concern (VOC) of SARS-CoV-2 in India
- Open Access
Androgen receptor plays critical role in regulating cervical cancer cell migration
Cervical cancer (CC) is the second most common cancer among women in India and the fourth worldwide. While major genes and pathways have been studied, further research is needed to identify candidates for targeted therapy in metastatic disease. This study used a network biology approach to identify key genes in disease progression. Stage-specific cervical cancer protein-protein interaction networks (PPIN) were constructed by overlaying stage-specific, patient-derived transcriptomics data onto a human protein-protein interaction network (HPPIN). Graph-theory-based network analysis identified important interacting proteins (IIPs) with maximum connectivity, high centrality scores, and significant global and local network perturbation scores. Among the identified IIPs, the Androgen receptor (AR) emerged as one of the crucial yet understudied regulator in cervical cancer. Patient samples and in vitro experiments showed significant downregulation in cervical cancer. Ligand-dependent overexpression of AR reduced cancer cell migration while failed to induce apoptosis in CC cell lines. Downregulation of mesenchymal markers and restoration of epithelial markers suggested AR’s potential in reversing invasive properties of cervical cancer cells. AR overexpression upregulated its downstream target PTEN and restored GSK3β activity by interfering with AKT phosphorylation, probably leading to degradation of mesenchymal markers. Further studies showed AR reduced cell motility by hindering focal adhesion formation and Actin filament assembly. An increased G-Actin ratio suggested AR disrupted cytoskeletal dynamics through the RhoA/ROCK1/LIMK1/CFL1 pathway, impeding cervical cancer cell spread.
Open AccessAndrogen receptor plays critical role in regulating cervical cancer cell migration
Cervical cancer (CC) is the second most common cancer among women in India and the fourth worldwide. While major genes and pathways have been studied, further research is needed to identify candidates for targeted therapy in metastatic disease. This study used a network biology approach to identify key genes in disease progression. Stage-specific cervical cancer protein-protein interaction networks (PPIN) were constructed by overlaying stage-specific, patient-derived transcriptomics data onto a human protein-protein interaction network (HPPIN). Graph-theory-based network analysis identified important interacting proteins (IIPs) with maximum connectivity, high centrality scores, and significant global and local network perturbation scores. Among the identified IIPs, the Androgen receptor (AR) emerged as one of the crucial yet understudied regulator in cervical cancer. Patient samples and in vitro experiments showed significant downregulation in cervical cancer. Ligand-dependent overexpression of AR reduced cancer cell migration while failed to induce apoptosis in CC cell lines. Downregulation of mesenchymal markers and restoration of epithelial markers suggested AR’s potential in reversing invasive properties of cervical cancer cells. AR overexpression upregulated its downstream target PTEN and restored GSK3β activity by interfering with AKT phosphorylation, probably leading to degradation of mesenchymal markers. Further studies showed AR reduced cell motility by hindering focal adhesion formation and Actin filament assembly. An increased G-Actin ratio suggested AR disrupted cytoskeletal dynamics through the RhoA/ROCK1/LIMK1/CFL1 pathway, impeding cervical cancer cell spread.